- Home
- LUMO vs OKYO Comparison
LUMO vs OKYO Comparison
Compare LUMO & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUMO
- OKYO
- Stock Information
- Founded
- LUMO 2011
- OKYO 2007
- Country
- LUMO United States
- OKYO United Kingdom
- Employees
- LUMO N/A
- OKYO N/A
- Industry
- LUMO Biotechnology: Pharmaceutical Preparations
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LUMO Health Care
- OKYO Health Care
- Exchange
- LUMO Nasdaq
- OKYO Nasdaq
- Market Cap
- LUMO 37.7M
- OKYO 38.2M
- IPO Year
- LUMO N/A
- OKYO 2022
- Fundamental
- Price
- LUMO $4.33
- OKYO $1.11
- Analyst Decision
- LUMO Buy
- OKYO Strong Buy
- Analyst Count
- LUMO 4
- OKYO 1
- Target Price
- LUMO $9.38
- OKYO $7.00
- AVG Volume (30 Days)
- LUMO 126.3K
- OKYO 128.1K
- Earning Date
- LUMO 11-07-2024
- OKYO 11-22-2024
- Dividend Yield
- LUMO N/A
- OKYO N/A
- EPS Growth
- LUMO N/A
- OKYO N/A
- EPS
- LUMO N/A
- OKYO N/A
- Revenue
- LUMO $2,205,000.00
- OKYO N/A
- Revenue This Year
- LUMO $184.11
- OKYO N/A
- Revenue Next Year
- LUMO N/A
- OKYO N/A
- P/E Ratio
- LUMO N/A
- OKYO N/A
- Revenue Growth
- LUMO 300.59
- OKYO N/A
- 52 Week Low
- LUMO $1.37
- OKYO $0.81
- 52 Week High
- LUMO $4.58
- OKYO $2.12
- Technical
- Relative Strength Index (RSI)
- LUMO 56.58
- OKYO 49.75
- Support Level
- LUMO $4.25
- OKYO $1.07
- Resistance Level
- LUMO $4.44
- OKYO $1.30
- Average True Range (ATR)
- LUMO 0.12
- OKYO 0.09
- MACD
- LUMO -0.03
- OKYO -0.01
- Stochastic Oscillator
- LUMO 33.33
- OKYO 18.52
About LUMO Lumos Pharma Inc.
Lumos Pharma Inc is a biopharmaceutical company that develops treatments for cancer and rare diseases. It carries out both clinical-stage and preclinical research on a range of molecules that help the immune system fight off cancer cells. The treatments are available orally and can be used in conjunction with other cancer therapies. The company also researches an Ebola vaccine. Lumos contracts with manufacturing organizations to make their treatments, engages in partnerships with pharmaceutical companies, and operates in the United States.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.